Related Experiment Video
Updated: Nov 1, 2025

Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
Estimated Cost-effectiveness of Solar-Powered Oxygen Delivery for Pneumonia in Young Children in Low-Resource
Yiming Huang1, Qaasim Mian1,2, Nicholas Conradi1,2
1University of Alberta, Edmonton, Canada.
Insights
Solar-powered oxygen delivery is a cost-effective solution for treating childhood pneumonia in low-resource settings. This technology saves lives by providing essential oxygen therapy where access is limited.
Area of Science:
- Global Health
- Pediatric Medicine
- Health Economics
Background:
- Pneumonia is the leading cause of death in children globally.
- Severe pneumonia requires oxygen therapy, but access is often limited in low- and middle-income countries (LMICs).
- Solar-powered oxygen (solar-powered O2) offers a reliable solution for medical oxygen delivery in resource-limited settings.
Purpose of the Study:
- To evaluate the cost-effectiveness of solar-powered O2 for treating children with severe pneumonia in LMICs.
- To provide economic data to guide the implementation of solar-powered O2 technology.
Main Methods:
- Economic evaluation conducted from January 2020 to February 2021, adhering to WHO-CHOICE guidelines.
- Analysis of solar-powered O2 implementation costs for pediatric patients (<5 years) requiring supplemental oxygen.
- Calculation of incremental cost-effectiveness ratio (ICER) per disability-adjusted life-year (DALY) saved, with sensitivity analyses.
Main Results:
- The ICER for solar-powered O2 was estimated at $20 per DALY saved compared to no oxygen.
- Alternative costings included $26 per patient treated and $542 per life saved.
- Solar-powered O2 was found to be cost-effective versus grid-powered systems and cost-saving versus generator-powered systems.
Conclusions:
- Solar-powered O2 is a cost-effective intervention for treating childhood hypoxemia in LMICs.
- Implementation should target areas with high pediatric pneumonia admission and mortality rates.
- The study supports the expansion of solar-powered O2 and further research into its efficacy and mortality benefits.
Importance:
Pneumonia is the leading cause of childhood mortality worldwide. Severe pneumonia associated with hypoxemia requires oxygen therapy; however, access remains unreliable in low- and middle-income countries. Solar-powered oxygen delivery (solar-powered O2) has been shown to be a safe and effective technology for delivering medical oxygen. Examining the cost-effectiveness of this innovation is critical for guiding implementation in low-resource settings.
Objective:
To determine the cost-effectiveness of solar-powered O2 for treating children in low-resource settings with severe pneumonia who require oxygen therapy.
Design, Setting, And Participants:
An economic evaluation study of solar-powered O2 was conducted from January 12, 2020, to February 27, 2021, in compliance with the World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) guidelines. Using existing literature, plausible ranges for component costs of solar-powered O2 were determined in order to calculate the expected total cost of implementation. The costs of implementing solar-powered O2 at a single health facility in low- and middle-income countries was analyzed for pediatric patients younger than 5 years who required supplemental oxygen.
Exposures:
Treatment with solar-powered O2.
Main Outcomes And Measures:
The incremental cost-effectiveness ratio (ICER) of solar-powered O2 was calculated as the additional cost per disability-adjusted life-year (DALY) saved. Sensitivity of the ICER to uncertainties of input parameters was assessed through univariate and probabilistic sensitivity analyses.
Results:
The ICER of solar-powered O2 was estimated to be $20 (US dollars) per DALY saved (95% CI, $2.83-$206) relative to the null case (no oxygen). Costs of solar-powered O2 were alternatively quantified as $26 per patient treated and $542 per life saved. Univariate sensitivity analysis found that the ICER was most sensitive to the volume of pediatric pneumonia admissions and the case fatality rate. The ICER was insensitive to component costs of solar-powered O2 systems. In secondary analyses, solar-powered O2 was cost-effective relative to grid-powered concentrators (ICER $140 per DALY saved) and cost-saving relative to fuel generator-powered concentrators (cost saving of $7120).
Conclusions And Relevance:
The results of this economic evaluation suggest that solar-powered O2 is a cost-effective solution for treating hypoxemia in young children in low- and middle-income countries, relative to no oxygen. Future implementation should prioritize sites with high rates of pediatric pneumonia admissions and mortality. This study provides economic support for expansion of solar-powered O2 and further assessment of its efficacy and mortality benefit.
Related Concept Videos
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Administering Oxygen by Mask
Administering oxygen by mask is a common nursing intervention that provides supplemental oxygen to patients with respiratory distress or chronic lung conditions. This procedure involves delivering oxygen at a specified rate through a face mask connected to an oxygen source.
Equipment
The equipment necessary for this procedure includes:

